The case for & against
Bull & Bear analysis
Align Technology, Inc. (NASDAQ: ALGN) is a leading player in the orthodontics and dental technology sector, specifically known for its product offerings in digital orthodontics, including the Invisalign clear aligner system and iTero scanning technology. The company predominantly operates via two segments: clear aligners and systems/services, positioning itself favorably amidst evolving consumer needs for orthodontic solutions, particularly through its innovations and digital enhancements.
Bull says
- ↑Q1 revenue $1.04B (+6.2% YoY) and aligner sales $856M (+7.4%).
- ↑Operating margin of 13.6% with $142M operating income.
- ↑Generated $151M cash from operations and $120.3M free cash flow.
- ↑International growth strong in EMEA/APAC, diversifying revenue.
- ↑Forward P/E ~15x signals investor optimism in growth.
- ↑Innovation via iTero scanners and new Pallet Expander drives market edge.
Bear says
- ↓Restructuring costs weigh on margins amid negative profitability factors.
- ↓Negative growth factors persist as retail segment remains mixed.
- ↓Inflation and geopolitical tensions risk dampening consumer demand.
- ↓Low-cost aligner competitors and DSOs pressure pricing and share.
- ↓High stock volatility and low short interest reflect investor caution.
- ↓Analyst mix (11 Buy, 4 Hold, 1 Sell) underscores outcome uncertainty.
Investment themes with ALGN
Stocks with high volatility relative to market
Earnings Call · Q1 2026 · Mgmt. Guidance
Transcript signals
Bull points
- First quarter overall gross margin was 70.8% up 1.4 points year-over-year, primarily due to operational efficiencies and higher clear aligner ASP.
- First quarter net income per diluted share was $1.57, up 31 cents compared to the prior year. Our EPS was favorably impacted by one cent on a year-over-year basis due to foreign exchange.
- We believe this action reflects our conviction that aligned shares remain attractively valued, supported by improving underlying business fundamentals.
Bear points
- Given the ongoing uncertainty, we have taken a prudent approach in our second quarter outlook by assuming some impact on both clear aligner and scanner demand.
- it becomes increasingly difficult to predict how the conflict in the Middle East will affect our business, particularly in the event of further escalation.
- I think you mentioned it was down a little bit year over year.